Feedback / Questions
CIT-013 - Citryll
https://www.globenewswire.com/news-release/2025/09/02/3142324/0/en/FIRST-PATIENT-DOSED-IN-CITRYLL-S-PHASE-IIA-TRIAL-EVALUATING-CIT-013-IN-RHEUMATOID-ARTHRITIS.html
Sep 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next